2 Quantitation of CD137 and Nectin-4 expression across multiple tumor types to support indication selection for BT7480, a Bicycle tumor-targeted immune cell agonist™ (Bicycle TICA™)

Heather Cohen; Carly Campbell; Kristen Hurov; Johanna Lahdenranta; Tara Gelb; David Galbraith; Dan Rozelle; Mate Nagy; Qingyan Au; Erinn Parnell; Phil Brandish; Sebastien Hazard; Dominic Smethurst; Nicholas Keen; Stephen Blakemore

doi:10.1136/jitc-2021-SITC2021.002

Article info

Regular and Young Investigator Award Abstracts

Biomarkers, Immune Monitoring, and Novel Technologies

2 Quantitation of CD137 and Nectin-4 expression across multiple tumor types to support indication selection for BT7480, a Bicycle tumor-targeted immune cell agonist™ (Bicycle TICA™)

Free

Authors

Heather Cohen Bicycle Therapeutics, Lexington, MA, USA PubMed articles Google scholar articles
Carly Campbell Bicycle Therapeutics, Lexington, MA, USA PubMed articles Google scholar articles
Kristen Hurov Bicycle Therapeutics, Lexington, MA, USA PubMed articles Google scholar articles
Johanna Lahdenranta Bicycle Therapeutics, Lexington, MA, USA PubMed articles Google scholar articles
Tara Gelb Bicycle Therapeutics, Lexington, MA, USA PubMed articles Google scholar articles
David Galbraith Rancho Bio Sciences, San Diego, USA PubMed articles Google scholar articles
Dan Rozelle Rancho Bio Sciences, San Diego, USA PubMed articles Google scholar articles
Mate Nagy NeoGenomics Laboratories, Aliso Viejo, USA PubMed articles Google scholar articles
Qingyan Au NeoGenomics Laboratories, Aliso Viejo, USA PubMed articles Google scholar articles
Erinn Parnell NeoGenomics Laboratories, Aliso Viejo, USA PubMed articles Google scholar articles
Phil Brandish Bicycle Therapeutics, Lexington, MA, USA PubMed articles Google scholar articles
Sebastien Hazard Bicycle Therapeutics, Lexington, MA, USA PubMed articles Google scholar articles
Dominic Smethurst Bicycle Therapeutics, Lexington, MA, USA PubMed articles Google scholar articles
Nicholas Keen Bicycle Therapeutics, Lexington, MA, USA PubMed articles Google scholar articles
Stephen Blakemore Bicycle Therapeutics, Lexington, MA, USA PubMed articles Google scholar articles

Citation

Cohen H, Campbell C, Hurov K, et al

2 Quantitation of CD137 and Nectin-4 expression across multiple tumor types to support indication selection for BT7480, a Bicycle tumor-targeted immune cell agonist™ (Bicycle TICA™)

Journal for ImmunoTherapy of Cancer 2021;9:doi: 10.1136/jitc-2021-SITC2021.002

Publication history

First published November 10, 2021.

Online issue publication

March 30, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Main menu

Authors

Citation

Publication history

Request permissions

Copyright information

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Publication history

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password